摘要
Graves病(GD),也称弥漫性甲状腺肿伴甲状腺功能亢进症,是一种由环境和遗传因素共同致病的多基因疾病。在目前公认的9个GD易感基因中,SCGB3A2是唯一一个利用标签单核苷酸多态性(tagSNP)技术、通过定位克隆策略识别鉴定的一个易感基因,并随后在英国和俄罗斯两个独立样本的研究中得到证实。目前多基因疾病研究专家一致认为SCGB3A2是GD的一个新的致病易感基因。
Graves′ disease is a common autoimmune disease triggered by the susceptibility genes and environmental factors. Among the 9 risk genes related to Graves′ disease, SCGB3A2 is the first Graves′ disease-predisposing gene identified by our group using tagSNPs, strategy of candidate genes, and positional clones. The association between SCGB3A2 and Graves′ disease has been confirmed by two independent cohorts from UK and Russia. So far, the geneticists on Graves′ disease regard SCGB3A2 as a validated susceptibility gene of that disease.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2013年第2期93-96,共4页
Chinese Journal of Endocrinology and Metabolism
关键词
格雷夫斯病
易感基因
多态性
单核苷酸
Graves' disease
Susceptibility gene
Polymorphism, single nucleotide